Research round-up, October 2026
What has been verified across the AP-4 field since the start of 2026: the SPG50 Phase 3 trial is enrolling, the ATG9A assay paper is out, a CRISPR screen named new drug targets, and SPG52 remains preclinical.
Updates
Dated posts. Research items are linked to their primary source; program status always defers to the UAB page.
-
-
This site is live
curespg52.com launches in English, built by families, with every research number traced to its source. What is here, what is still being confirmed, and what comes next.